Intensified mycophenolate mofetil (MMF) dosing is safe from the standpoint of engraftment and reduces severe acute graft-versus-host disease (aGVHD) after double-unit cord blood transplantation (DCBT): An analysis of 173 patients

Authors :: Ponce, D. M.
Harnicar, S.
Hilden, P.
Devlin, S.
Evans, K.
Lubin, M.
Nancy Kernan
Prockop, S. E.
Scaradavou, A.
Giralt, S. A.
Goldberg, J. D.
Perales, M. A.
Barker, J. N.
Source :: Memorial Sloan Kettering Cancer Center

Tools